A Pharmacovigilance Analysis of Daptomycin Use Based on CLSI Susceptible Dose-Dependent Category
ConclusionHigh-dose daptomycin was not associated with increased laboratory abnormalities or adverse drug reactions compared to standard-dose daptomycin.
Source: Infectious Diseases and Therapy - Category: Infectious Diseases Source Type: research
More News: Cholesterol | Cubicin | Drugs & Pharmacology | Infectious Diseases | Laboratory Medicine | Statin Therapy | Study